Influence of ocular volume and lens status on pharmacokinetics and duration of action of intravitreal vascular endothelial growth factor inhibitors. [electronic resource]
Producer: 20150618Description: 69-74 p. digitalISSN:- 1539-2864
- Angiogenesis Inhibitors -- pharmacokinetics
- Antibodies, Monoclonal, Humanized -- pharmacokinetics
- Aqueous Humor -- metabolism
- Axial Length, Eye -- anatomy & histology
- Bevacizumab
- Biological Availability
- Enzyme-Linked Immunosorbent Assay
- Female
- Humans
- Intravitreal Injections
- Lens, Crystalline -- physiology
- Macular Edema -- drug therapy
- Male
- Middle Aged
- Ranibizumab
- Refraction, Ocular -- physiology
- Retinal Diseases -- drug therapy
- Retinal Vein Occlusion -- drug therapy
- Time Factors
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Wet Macular Degeneration -- drug therapy
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.